(NU/1433-27) iFAST: The Provision of Business Consultancy to Assist Commercialisation of University Research.

Award

Value

£30,000

Classifications

  • Business and management consultancy and related services

Tags

  • award
  • contract

Published

3 years ago

Description

The emergence of bacteria that are resistant to antibiotics is a growing public health problem. In 2015, there were nearly 700,0000 antimicrobial resistance (AMR) infections in the EU, accounting for 33,000 deaths and 900,000 disability-adjusted life years (DALYs) . In fact the impact of AMR is similar to the combined burden of influenza, tuberculosis, and HIV, and the global increases in healthcare costs is forecast to range from $300 billion to more than $1 trillion per year by 2050.
We have developed a breakthrough technology that delivers an antibiotic resistance test result in 1 hour. The technique rapidly measures phenotypic changes in bacteria after exposure to antibiotics.
The objective is for the Executive (CEO Desig) to jointly work in a team with all above named individuals to bring the opportunity towards and ultimately achieve launch of a new spinout company.

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download
  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Timeline complete

Publish
Bid
Evaluate
Award
Complete